specialty drugs : Latest News, Videos and Photos | Outlook Business
Home » Search
Search Result : "specialty drugs"

Amidst macro concerns and volatile stock, promoters of Aarti Industries sell shares worth Rs.1.64 billion

Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?

Despite the strong industry headwind, Torrent Pharma remains in the pink of health, thanks to its diversified geographical presence and specialty products

Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs

As the market tumbles, mutual fund managers recommend pharma, private banks and specialty chemicals to tide over the volatility

The worst seems to be behind for Sun Pharma as its Halol plant seems set for clearance and its specialty portfolio tests water in the US

The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon

A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players

Lupin is betting on its specialty drugs business to counter the pricing pressures in the US generics market 

Not content with the initial win in biosimiliars, Kiran Mazumdar-Shaw is pushing new frontiers in biologics

Regulatory woes continue to pile up for pharma companies

Deepak Fertilisers stands to gain from its vertically integrated operations and leadership position in key specialty chemicals 

Sun Pharma has a robust pipeline in specialty business which will drive its profitability and free cash flow in the near future 

Impulse Social Enterprises is ensuring sustainable livelihoods in the northeast

The specialty chemicals player is ramping up capacity to keep growth ticking

Drug majors are shifting clinical trials out of India as lawmakers turn on the heat

Lupin wants to keep bingeing on overseas markets and specialty segments for growth

Dr Reddy's is adapting to industry dynamics and seizing opportunities while staying true to the founder’s vision

He has tirelessly fought against a monopoly in life-saving drugs. Fighting alone has failed to dissuade him

The Ambur cluster is weathering power cuts and strict pollution control norms

How Suresh Soni and others are transforming India’s healthcare landscape

Tectonic changes in the US generic drugs market is causing  huge shifts in Indian pharma’s strategies as well